Cargando…

Dynamics of viral replication in blood and lymphoid tissues during SIVmac251 infection of macaques

BACKGROUND: Extensive studies of primary infection are crucial to our understanding of the course of HIV disease. In SIV-infected macaques, a model closely mimicking HIV pathogenesis, we used a combination of three markers -- viral RNA, 2LTR circles and viral DNA -- to evaluate viral replication and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mannioui, Abdelkrim, Bourry, Olivier, Sellier, Pierre, Delache, Benoit, Brochard, Patricia, Andrieu, Thibault, Vaslin, Bruno, Karlsson, Ingrid, Roques, Pierre, Le Grand, Roger
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789052/ https://www.ncbi.nlm.nih.gov/pubmed/19930655 http://dx.doi.org/10.1186/1742-4690-6-106

Ejemplares similares

Antiretroviral Treatment Start-Time during Primary SIV(mac) Infection in Macaques Exerts a Different Impact on Early Viral Replication and Dissemination
por: Sellier, Pierre, et al.
Publicado: (2010)

Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
por: Bourry, Olivier, et al.
Publicado: (2009)

Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion
por: Bourry, Olivier, et al.
Publicado: (2010)

Repeated semen exposure decreases cervicovaginal SIVmac251 infection in rhesus macaques
por: Abdulhaqq, Shaheed A., et al.
Publicado: (2019)

SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
por: Villefroy, Pascale, et al.
Publicado: (2006)

P20-13. Identification and characterization of early founder populations in Rhesus macaques vaginally infected with SIVmac251
por: Stone, M, et al.
Publicado: (2009)

Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques
por: Abreu, Celina M., et al.
Publicado: (2019)

Early Divergent Host Responses in SHIVsf162P3 and SIVmac251 Infected Macaques Correlate with Control of Viremia
por: Xu, Huanbin, et al.
Publicado: (2011)

Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251
por: Mattathil, Jeffy G., et al.
Publicado: (2023)

Reconstitution of the myeloid and lymphoid compartments after the transplantation of autologous and genetically modified CD34(+ )bone marrow cells, following gamma irradiation in cynomolgus macaques
por: Derdouch, Sonia, et al.
Publicado: (2008)

Low autocrine interferon beta production as a gene therapy approach for AIDS: Infusion of interferon beta-engineered lymphocytes in macaques chronically infected with SIVmac251
por: Gay, Wilfried, et al.
Publicado: (2004)

Antibodies to the envelope protein protect macaques from SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial
por: Franchini, G, et al.
Publicado: (2012)

Epigenetic drug Gar1041 in combination with antiretroviral therapy transiently reduces the proviral DNA reservoir in SIVmac251-infected macaques
por: Lewis, MG, et al.
Publicado: (2010)

P03-11. DNA vaccination with IL-12 lowers viral replication following SIVmac251 challenge
por: Hirao, LA, et al.
Publicado: (2009)

Preservation of a subset of SIV-specific central memory CD4+ T cells correlates with control of viremia in SIVmac251 infected macaques
por: Felber, Barbara K, et al.
Publicado: (2006)

Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1
por: Keele, Brandon F., et al.
Publicado: (2009)

Chronic Morphine Administration Differentially Modulates Viral Reservoirs in a Simian Immunodeficiency Virus SIVmac251-Infected Rhesus Macaque Model
por: Acharya, Arpan, et al.
Publicado: (2021)

Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy
por: Whitney, James B., et al.
Publicado: (2018)

P19-49. Modulation of vaccine induced responses through CTLA-4 and 41BB enhances protection in macaques following SIVmac251 challenge
por: Hirao, LA, et al.
Publicado: (2009)

Intra-dermal immunisation with SIV gag-based vaccines alone inhibits acquisition of SIVmac251
por: Almond, N, et al.
Publicado: (2012)

Vaccine protection against rectal acquisition of SIVmac239 in rhesus macaques
por: Gonzalez-Nieto, Lucas, et al.
Publicado: (2019)

Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques
por: Virnik, Konstantin, et al.
Publicado: (2020)

Location and Dynamics of the Immunodominant CD8 T Cell Response to SIVΔnef Immunization and SIVmac251 Vaginal Challenge
por: Sasikala-Appukuttan, Arun K., et al.
Publicado: (2013)

P03-08. Protection against SIVmac239 challenge in a rhesus macaque model conferred by a doxycycline dependent attenuated SIVmac239
por: Page, M, et al.
Publicado: (2009)

Productive Replication of HIV-1 but Not SIVmac in Small Ruminant Cells
por: Chergui, Hibet Errahmane, et al.
Publicado: (2022)

Characterization in rabbits & nonhuman primates of the neutralizing antibody response elicited by DNA & protein vaccination with SIVmac251 & SIVsmE660
por: Menon, VP, et al.
Publicado: (2012)

Mapping of SIVmac T-cell epitopes in cynomolgus macaques immunized with auxo-GTU-MultiSIV DNA by the intradermal route followed by electroporation
por: Corneau, A, et al.
Publicado: (2012)

CD8+ Lymphocytes Control Viral Replication in SIVmac239-Infected Rhesus Macaques without Decreasing the Lifespan of Productively Infected Cells
por: Klatt, Nichole R., et al.
Publicado: (2010)

Contributions of Mamu-A*01 Status and TRIM5 Allele Expression, But Not CCL3L Copy Number Variation, to the Control of SIVmac251 Replication in Indian-Origin Rhesus Monkeys
por: Lim, So-Yon, et al.
Publicado: (2010)

Immune Modulation through 4-1BB Enhances SIV Vaccine Protection in Non-Human Primates against SIVmac251 Challenge
por: Hirao, Lauren A., et al.
Publicado: (2011)

Dendritic cell subsets dynamics and cytokine production in SIVmac239-infected Chinese rhesus macaques
por: Xia, Hou-Jun, et al.
Publicado: (2010)

Non-neutralizing Antibodies May Contribute to Suppression of SIVmac239 Viremia in Indian Rhesus Macaques
por: Pedreño-Lopez, Nuria, et al.
Publicado: (2021)

Neuropathology of wild-type and nef-attenuated T cell tropic simian immunodeficiency virus (SIVmac32H) and macrophage tropic neurovirulent SIVmac17E-Fr in cynomolgus macaques
por: Clarke, Sean, et al.
Publicado: (2012)

Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251: increased diversity is associated with neutralizing antibodies and improved survival in previously immunized animals
por: Greenier, Jennifer L, et al.
Publicado: (2005)

P14-08. Intramuscular DNA delivery by electroporation leads to greatly enhanced systemic and mucosal immune responses and control of SIVmac251 challenge
por: Pavlakis, GN, et al.
Publicado: (2009)

Parasites may exit immunocompromised northern pig-tailed macaques (Macaca leonina) infected with SIVmac239
por: Song, Tian-Zhang, et al.
Publicado: (2018)

OA06-02. Monospecific expansion of SIVmac251 during acute infection masks multiple transmitted virus variants revealed during the chronic phase
por: Felber, BK, et al.
Publicado: (2009)

Complete Genome Sequence of a Reference Stock of Simian Immunodeficiency Virus RNA (SIVmac251/32H/L28) Determined by Deep Sequencing
por: Jenkins, Adrian, et al.
Publicado: (2016)

Comprehensive mapping of SIVmac239 envelope antigenic determinants recognized by specific polyclonal antibodies in vaccinated and/or infected macaques
por: Guo, J, et al.
Publicado: (2012)

Generation of Neutralizing Antibodies and Divergence of SIVmac239 in Cynomolgus Macaques Following Short-Term Early Antiretroviral Therapy
por: Özkaya Şahin, Gülşen, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_mh98d6u7mgshtnk8i8cu41f8ot